Movement Alert|Core Scientific Rises 5.41% in Regular Trading, Oversold Rebound After Acquisition Termination Combined With Computing Sector Strength

Market Focus06-12

On June 12, Core Scientific rose 5.41% in regular trading, trading at $27.11/share, with turnover of $189 million. The stock extended its recovery pattern following the termination of its $9 billion all-stock acquisition agreement with Nvidia-backed CoreWeave after shareholders voted to reject the deal.

The acquisition termination was formally announced in early June, triggering a cumulative decline of approximately 10% over consecutive sessions as the market repriced the loss of a major valuation catalyst. The current price remains well below the B.Riley upgraded target of $33 and the analyst consensus target of $30.12, indicating clear valuation repair potential that has attracted dip-buying capital.

On the sector front, computing power-related names provided strong co-movement support, with IREN Ltd surging 8.76% in the same session. Core Scientific is a leader in designing, building, and operating high-performance computing digital infrastructure, having expanded from digital asset mining into third-party hosting services for AI and machine learning workloads.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment